Antiviral activity of flavonol against porcine epidemic diarrhea virus
- PMID: 38861876
- DOI: 10.1016/j.virol.2024.110128
Antiviral activity of flavonol against porcine epidemic diarrhea virus
Abstract
Porcine epidemic diarrhea virus (PEDV) remains one of the major causative microorganisms of viral diarrhea in piglets worldwide, with no approved drugs for treatment. We identified a natural molecule, flavonol, which is widely found in tea, vegetables and herbs. Subsequently, the antiviral activity of compound flavonol was evaluated in Vero cells and IPEC-J2 cells, and its anti-PEDV mechanism was analyzed by molecular docking and molecular dynamics. The results showed that flavonol could effectively inhibit viral progeny production, RNA synthesis and protein expression of PEDV strains in a dose-dependent manner. When flavonol was added simultaneously with viral infection in Vero cells, it demonstrated potent anti-PEDV activity by affecting the viral attachment and internalization phases. Similarly, in IPEC-J2 cells, flavonol effectively inhibited PEDV infection at different stages of infection, except for the release phase. Moreover, flavonol mainly interacts with PEDV Mpro through hydrogen bonds and hydrophobic forces, and the complex formed by it has high stability. Importantly, flavonol also showed broad-spectrum activity against other porcine enteric coronaviruses such as TGEV and PDCoV in vitro. These findings suggest that flavonol may exert antiviral effects by interacting with viral Mpro, thereby affecting viral replication. This means that flavonol is expected to become a potential drug to prevent or treat porcine enteric coronavirus.
Keywords: Antiviral activity; Coronavirus; Flavonol; Porcine epidermic diarrhea virus.
Copyright © 2024 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Advances research in porcine enteric coronavirus therapies and antiviral drugs.Vet Q. 2024 Dec;44(1):1-49. doi: 10.1080/01652176.2024.2421299. Epub 2024 Nov 1. Vet Q. 2024. PMID: 39484691 Free PMC article. Review.
-
Coronavirus Porcine Epidemic Diarrhea Virus Nucleocapsid Protein Interacts with p53 To Induce Cell Cycle Arrest in S-Phase and Promotes Viral Replication.J Virol. 2021 Jul 26;95(16):e0018721. doi: 10.1128/JVI.00187-21. Epub 2021 Jul 26. J Virol. 2021. PMID: 34037422 Free PMC article.
-
PA-824 inhibits porcine epidemic diarrhea virus infection in vivo and in vitro by inhibiting p53 activation.J Virol. 2024 Jul 23;98(7):e0041323. doi: 10.1128/jvi.00413-23. Epub 2024 Jun 12. J Virol. 2024. PMID: 38864728 Free PMC article.
-
Ethyl caffeate as a novel targeted inhibitor of 3CLpro with antiviral activity against porcine epidemic diarrhea virus.Virology. 2025 Mar;604:110406. doi: 10.1016/j.virol.2025.110406. Epub 2025 Jan 16. Virology. 2025. PMID: 39854915
-
Antiviral activity of luteolin against porcine epidemic diarrhea virus in silico and in vitro.BMC Vet Res. 2024 Jul 3;20(1):288. doi: 10.1186/s12917-024-04053-4. BMC Vet Res. 2024. PMID: 38961481 Free PMC article.
Cited by
-
Advances research in porcine enteric coronavirus therapies and antiviral drugs.Vet Q. 2024 Dec;44(1):1-49. doi: 10.1080/01652176.2024.2421299. Epub 2024 Nov 1. Vet Q. 2024. PMID: 39484691 Free PMC article. Review.
-
An overview of natural herbal extracts and compounds for combating porcine epidemic diarrhea virus.Front Vet Sci. 2025 Jun 6;12:1557198. doi: 10.3389/fvets.2025.1557198. eCollection 2025. Front Vet Sci. 2025. PMID: 40548251 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources